Prices are updated after-hours


Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date

tags : Myeloid leukemia    symbols : ABBV    save search

Acute Myeloid Leukemia (AML) Treatment Market size in APAC to grow by USD 277.03 Million | Driven by high incidence of acute myeloid leukemia | Technavio
Published: 2022-03-07 (Crawled : 11:00) - prnewswire.com
GLAXF | News | $20.2 -14.18% 510 twitter stocktwits trandingview |
Health Technology
| | O: 0.0% H: 0.0% C: 0.0%
NVSEF | $93.6375 6.88% 82K twitter stocktwits trandingview |
Health Technology
| | O: -0.26% H: 0.0% C: 0.0%
ALPMY | $9.47 -1.11% 520K twitter stocktwits trandingview |
Manufacturing
| | O: 1.58% H: 0.0% C: -0.87%
NVS | $94.36 1.93% 0.0% 2.3M twitter stocktwits trandingview |
Health Technology
| | O: -0.63% H: 0.0% C: 0.0%
GSK | News | $39.75 1.22% 0.0% 1.6M twitter stocktwits trandingview |
Health Technology
| | O: -0.7% H: 0.0% C: 0.0%
ABBV | $166.41 1.06% 0.0% 5.5M twitter stocktwits trandingview |
Health Technology
| | O: -0.01% H: 0.0% C: 0.0%

treatment myeloid leukemia leukemia acute myeloid leukemia aml
Global Acute Myeloid Leukemia (AML) Therapeutics Market Report 2021-2026: Ballooning Elderly Population - The Vital Growth Driver for AML Therapeutics
Published: 2021-12-06 (Crawled : 12:00) - prnewswire.com
ALPMF | $9.17 43.47% 16K twitter stocktwits trandingview |
Health Technology
| | O: -1.49% H: 1.45% C: 0.92%
NVSEF | $93.6375 6.88% 82K twitter stocktwits trandingview |
Health Technology
| | O: 2.02% H: 0.04% C: -0.89%
IMNPQ | $0.001 twitter stocktwits trandingview |
Manufacturing
| | O: 50.0% H: 0.0% C: -33.33%
ALPMY | $9.47 -1.11% 520K twitter stocktwits trandingview |
Manufacturing
| | O: -3.39% H: 3.45% C: 3.3%
NVS | $94.36 1.93% 0.0% 2.3M twitter stocktwits trandingview |
Health Technology
| | O: -0.57% H: 0.0% C: 0.0%
ABBV | $166.41 1.06% 0.0% 5.5M twitter stocktwits trandingview |
Health Technology
| | O: 1.57% H: 0.0% C: 0.0%
MEIP | $3.3 1.54% 1.52% 26K twitter stocktwits trandingview |
Health Technology
| | O: -4.4% H: 0.0% C: 0.0%
JAZZ | $109.96 0.63% 0.63% 760K twitter stocktwits trandingview |
Health Technology
| | O: -2.16% H: 0.0% C: 0.0%
CYCC | $1.85 -5.38% 10K twitter stocktwits trandingview |
Health Technology
| | O: -5.93% H: 0.0% C: 0.0%
CTIC | $9.09 0.05% 11M twitter stocktwits trandingview |
Health Technology
| | O: 7.24% H: 0.0% C: 0.0%
AMGN | $269.03 2.39% 2.33% 3.4M twitter stocktwits trandingview |
Health Technology
| | O: 2.53% H: 0.0% C: 0.0%
AGIO | $29.52 0.31% 0.3% 750K twitter stocktwits trandingview |
Health Technology
| | O: -5.47% H: 0.0% C: 0.0%

myeloid leukemia leukemia therapeutics growth acute myeloid leukemia aml
Global Acute Myeloid Leukemia (AML) Therapeutics Market to Reach $976.2 Billion by 2026
Published: 2021-08-11 (Crawled : 12:00) - prnewswire.com
NVS | $94.36 1.93% 0.0% 2.3M twitter stocktwits trandingview |
Health Technology
| | O: 0.51% H: 0.13% C: -0.27%
ABBV | $166.41 1.06% 0.0% 5.5M twitter stocktwits trandingview |
Health Technology
| | O: 0.3% H: 0.16% C: -1.25%
MEIP | $3.3 1.54% 1.52% 26K twitter stocktwits trandingview |
Health Technology
| | O: 0.37% H: 0.36% C: 0.0%
JAZZ | $109.96 0.63% 0.63% 760K twitter stocktwits trandingview |
Health Technology
| | O: -0.09% H: 1.32% C: 0.35%
CYCC | $1.85 -5.38% 10K twitter stocktwits trandingview |
Health Technology
| | O: -0.19% H: 0.19% C: -0.76%
CTIC | $9.09 0.05% 11M twitter stocktwits trandingview |
Health Technology
| | O: 1.73% H: 0.34% C: -7.14%
AMGN | $269.03 2.39% 2.33% 3.4M twitter stocktwits trandingview |
Health Technology
| | O: 0.52% H: 0.38% C: -0.44%
AGIO | $29.52 0.31% 0.3% 750K twitter stocktwits trandingview |
Health Technology
| | O: 0.07% H: 1.52% C: -0.32%

myeloid leukemia leukemia acute myeloid leukemia aml
FDA grants regular approval to venetoclax in combination for untreated acute myeloid leukemia
Published: 2021-06-11 (Crawled : 14:04) - fda.gov
ABBV | $166.41 1.06% 0.0% 5.5M twitter stocktwits trandingview |
Health Technology
| | O: 0.0% H: 0.1% C: -0.71%

fda granted approval leukemia myeloid leukemia grant acute myeloid leukemia
AbbVie Receives Positive CHMP Opinion for VENCLYXTO® (venetoclax) as a Combination Regimen for Adult Patients with Newly Diagnosed Acute Myeloid Leukemia Who Are Ineligible for Intensive Chemotherapy
Published: 2021-04-23 (Crawled : 14:00) - biospace.com/
ABBV | $166.41 1.06% 0.0% 5.5M twitter stocktwits trandingview |
Health Technology
| | O: -0.31% H: 1.88% C: 1.52%

myeloid leukemia positive therapy leukemia chmp acute myeloid leukemia
Gainers vs Losers
67% 33%

Top 10 Gainers
AGBA | News | $1.26 215.0% 68.25% 130M twitter stocktwits trandingview |
Finance

EGOX | $0.0515 43.06% 30.1% 330M twitter stocktwits trandingview |

OLB 4 | $0.33 -14.95% 25.53% 840K twitter stocktwits trandingview |
Technology Services

NVFY | $2.77 31.28% 23.83% 33M twitter stocktwits trandingview |
Consumer Durables

ZCMD | $1.87 28.97% 22.46% 31M twitter stocktwits trandingview |
Commercial Services

RCON | $0.1112 13.01% 21.28% 1.7M twitter stocktwits trandingview |
Distribution Services

INSG | $3.03 25.21% 20.13% 330K twitter stocktwits trandingview |
Electronic Technology

GCTK | $0.8191 22.25% 18.2% 190K twitter stocktwits trandingview |
Manufacturing

WLGS | $0.59 18.0% 17.9% 2.3M twitter stocktwits trandingview |

ASNS | $0.828 21.75% 17.86% 18K twitter stocktwits trandingview |


Your saved searches
Save your searches and get alerts when important news are released.